Clinical Trial Update: Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon [NA]

View source ↗

Summary

The ramelteon trial for sleep/wake disturbances in basal ganglia disorders has been withdrawn, involving Huntington's disease and Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies
• Huntington Disease
• Parkinson Disease

Drugs mentioned

• Ramelteon (ramelteon)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Huntington's Disease, Parkinson's Disease | NA | Status: WITHDRAWN